Literature DB >> 7755624

Interaction of protein 4.1 with the red cell membrane: effects of phosphorylation by protein kinase C.

J C Pinder1, B Gardner, W B Gratzer.   

Abstract

Phosphorylation with endogenous protein kinase C causes the membrane skeletal protein, band 4.1, to lose its capacity to attach to one of two classes of high-affinity binding sites on the red cell membrane. These sites are the ones eliminated by proteolysis in situ of glycophorin C; the surviving type of site is located in a C-terminal peptide of the glycophorin C, retained on the membrane after proteolysis, which is also the site of attachment of p55. A synthetic peptide, comprising the 28 C-terminal residues of glycophorin C, also binds protein 4.1. Phosphorylation of the intact cells, stimulated by phorbol ester, approximately halves the retention of glycophorin C in the membrane cytoskeletons prepared from these cells and reduces the affinity of extracellular glycophorin C epitopes for their antibody.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7755624     DOI: 10.1006/bbrc.1995.1685

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  4 in total

1.  Actin protofilament orientation at the erythrocyte membrane.

Authors:  C Picart; D E Discher
Journal:  Biophys J       Date:  1999-08       Impact factor: 4.033

2.  Regulation of AMPA receptor GluR1 subunit surface expression by a 4. 1N-linked actin cytoskeletal association.

Authors:  L Shen; F Liang; L D Walensky; R L Huganir
Journal:  J Neurosci       Date:  2000-11-01       Impact factor: 6.167

Review 3.  Tumor suppressor role of protein 4.1B/DAL-1.

Authors:  Zi Wang; Ji Zhang; Mao Ye; Min Zhu; Bin Zhang; Mridul Roy; Jing Liu; Xiuli An
Journal:  Cell Mol Life Sci       Date:  2014-09-03       Impact factor: 9.261

4.  A FERM-adjacent (FA) region defines a subset of the 4.1 superfamily and is a potential regulator of FERM domain function.

Authors:  Anthony J Baines
Journal:  BMC Genomics       Date:  2006-04-20       Impact factor: 3.969

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.